Press & Media

  • Jan 23, 2014
    Vela Diagnostics launches qualitative test to identify never before documented virus in Western hemisphere  
    For full story, –> Media Release – CHIKV 
  • Dec 19, 2013
    Vela Diagnostics launches first NRAS test for mutation detection in Melanoma and Thyroid Cancer
     For full story, –> Media Release – Vela NRAS
  • January 30, 2013
    Vela Diagnostics Signs an agreement with Thomas Jefferson University and Hospitals to Jointly Develop Next Generation Molecular Diagnostic Assays for Oncology and Virology.
    For full story, –> Media Release – VelaDx and TJUH
  • December 02, 2012
    VelaDx Signs License Agreement with Swift Biosciences to utlize Swift’s myT® Primer technology.
    For full story, –> Media Release_VelaDx and Swift Bio